EATRIS-Finland Infrastructure Services for Translational Medicine
EATRIS (European Infrastructure for Translational Medicine) is an EU-ERIC with 13 member states, 113 academic and non-profit research institutes and >1000 translational scientists across EU. According to EATRIS headquarters, EATRIS-Finland is one of the most advanced national EATRIS nodes with expertise and validated services in key areas of EATRIS operations.
With the advances in genomics and biomedical sciences, huge opportunities are emerging for the treatment and diagnostics of many severe currently untreatable diseases. Most new developments fall under a regulatory class called Advanced Therapy Medicinal Products (ATMP). Strict regulatory requirements for manufacturing, testing and translational studies are needed before these biological products can be brought to clinical use. Accordingly, there is an increasing and very significant world-wide demand for high quality preclinical and translational services needed both by academic scientists and SME-driven programs to fulfill all regulatory guidelines which are impossible to meet by small academic groups or SMAs with limited resources.
